Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 11/2004

01-11-2004 | Laboratory Investigation

Neuropeptide Y-evoked proliferation of retinal glial (Müller) cells

Authors: Ivan Milenkovic, Michael Weick, Peter Wiedemann, Andreas Reichenbach, Andreas Bringmann

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 11/2004

Login to get access

Abstract

Background

Glial cells in human retinas and in fibrocellular membranes from patients with proliferative vitreoretinopathy (PVR) have been described to upregulate their expression of Y1 receptors for neuropeptide Y (NPY) (Soler et al.: Glia 39:320, 2002). However, it is unknown whether Y1 receptor activation causes proliferation of retinal glial cells. We investigated whether NPY exerts a proliferation-stimulating effect on retinal glial cells, and compared the NPY-evoked signaling with the signaling of purinergic P2Y receptors.

Methods

Proliferation assays using bromodeoxyuridine were carried out on primarily cultured Müller glial cells of the guinea pig, in the absence and presence of blockers of Y1 receptors, of receptor tyrosine kinases (RTKs), of mitogen-activated protein kinases (MAPKs) and of phosphatidylinositol-3 kinase (PI3K).

Results

NPY exerted a biphasic effect on Müller cell proliferation. At low concentrations (0.1 ng/ml and 1 ng/ml) it decreased the proliferation rate of the cells, while at higher concentration (100 ng/ml) it increased Müller cell proliferation. The NPY-evoked proliferation was mediated by Y1 receptor stimulation and by activation of the p44/p42 MAPKs and partially of the p38 MAPK. Moreover, Y1 receptor-induced activation of PI3K as well as transactivations of the platelet-derived and the epidermal growth factor RTKs were necessary for full mitogenic effect of NPY. Y1 and P2Y receptors share partially common signal transduction pathways in Müller cells.

Conclusion

It is suggested that NPY may be involved in stimulation of retinal glial cell proliferation during PVR when it is released at higher amounts into the injured retina.
Literature
1.
go back to reference Andrews A, Balciunaite E, Leong FL, Tallquist M, Soriano P, Refojo M, Kazlauskas A (1999) Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 40:2683–2689PubMed Andrews A, Balciunaite E, Leong FL, Tallquist M, Soriano P, Refojo M, Kazlauskas A (1999) Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 40:2683–2689PubMed
2.
go back to reference Bruun A, Ehringer B, Sundler F, Tornquist K, Uddman R (1984) Neuropeptide Y immunoreactive neurons in the guinea-pig uvea and retina. Invest Ophthalmol Vis Sci 25:1113–1123PubMed Bruun A, Ehringer B, Sundler F, Tornquist K, Uddman R (1984) Neuropeptide Y immunoreactive neurons in the guinea-pig uvea and retina. Invest Ophthalmol Vis Sci 25:1113–1123PubMed
3.
go back to reference Cassidy L, Barry P, Shaw C, Duffy J, Kennedy S (1998) Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 82:181–185PubMed Cassidy L, Barry P, Shaw C, Duffy J, Kennedy S (1998) Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 82:181–185PubMed
4.
go back to reference Charteris DG (1995) Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol 79:953–960PubMed Charteris DG (1995) Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol 79:953–960PubMed
5.
go back to reference Daub H, Weiss FU, Wallasch C, Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379:557–560CrossRefPubMed Daub H, Weiss FU, Wallasch C, Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379:557–560CrossRefPubMed
6.
go back to reference Doughty MB, Chu SS, Miller DW, Li K, Tessel RE (1990) Benextramine: a long-lasting neuropeptide Y receptor antagonist. Eur J Pharmacol 185:113–114CrossRefPubMed Doughty MB, Chu SS, Miller DW, Li K, Tessel RE (1990) Benextramine: a long-lasting neuropeptide Y receptor antagonist. Eur J Pharmacol 185:113–114CrossRefPubMed
7.
go back to reference Fisher SK, Erickson PA, Lewis GP, Anderson DH (1991) Intraretinal proliferation induced by retinal detachment. Invest Ophthalmol Vis Sci 32:1739–1748PubMed Fisher SK, Erickson PA, Lewis GP, Anderson DH (1991) Intraretinal proliferation induced by retinal detachment. Invest Ophthalmol Vis Sci 32:1739–1748PubMed
8.
go back to reference Francke M, Weick M, Pannicke T, Uckermann O, Grosche J, Goczalik I, Milenkovic I, Uhlmann S, Faude F, Wiedemann P, Reichenbach A, Bringmann A (2002) Upregulation of extracellular ATP-induced Muller cell responses in a dispase model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 43:870–881PubMed Francke M, Weick M, Pannicke T, Uckermann O, Grosche J, Goczalik I, Milenkovic I, Uhlmann S, Faude F, Wiedemann P, Reichenbach A, Bringmann A (2002) Upregulation of extracellular ATP-induced Muller cell responses in a dispase model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 43:870–881PubMed
9.
go back to reference Guerin CJ, Wolfshagen RW, Eifrig DE, Anderson DH (1990) Immunocytochemical identification of Muller’s glia as a component of human epiretinal membranes. Invest Ophthalmol Vis Sci 31:1483–1491PubMed Guerin CJ, Wolfshagen RW, Eifrig DE, Anderson DH (1990) Immunocytochemical identification of Muller’s glia as a component of human epiretinal membranes. Invest Ophthalmol Vis Sci 31:1483–1491PubMed
10.
go back to reference Hinton DR, He S, Jin ML, Barron E, Ryan SJ (2002) Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye 16:422–428CrossRefPubMed Hinton DR, He S, Jin ML, Barron E, Ryan SJ (2002) Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye 16:422–428CrossRefPubMed
11.
go back to reference Hiscott PS, Grierson I, Trombetta CJ, Rahi AH, Marshall J, McLeod D (1984) Retinal and epiretinal glia—an immunohistochemical study. Br J Ophthalmol 68:698–707PubMed Hiscott PS, Grierson I, Trombetta CJ, Rahi AH, Marshall J, McLeod D (1984) Retinal and epiretinal glia—an immunohistochemical study. Br J Ophthalmol 68:698–707PubMed
12.
go back to reference Ikuno Y, Leong F-L, Kazlauskas A (2000) Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor. Invest Ophthalmol Vis Sci 41:3107–3116PubMed Ikuno Y, Leong F-L, Kazlauskas A (2000) Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor. Invest Ophthalmol Vis Sci 41:3107–3116PubMed
13.
go back to reference Kastin AJ, Akerstrom V (1999) Nonsaturable entry of neuropeptide Y into brain. Am J Physiol 276:E479–E482PubMed Kastin AJ, Akerstrom V (1999) Nonsaturable entry of neuropeptide Y into brain. Am J Physiol 276:E479–E482PubMed
14.
go back to reference Kodal H, Weick M, Moll V, Biedermann B, Reichenbach A, Bringmann A (2000) Involvement of calcium-activated potassium channels in the regulation of DNA synthesis in cultured Müller glial cells. Invest Ophthalmol Vis Sci 41:4262–4267PubMed Kodal H, Weick M, Moll V, Biedermann B, Reichenbach A, Bringmann A (2000) Involvement of calcium-activated potassium channels in the regulation of DNA synthesis in cultured Müller glial cells. Invest Ophthalmol Vis Sci 41:4262–4267PubMed
15.
go back to reference Kovalenko M, Gazit A, Bohmer A, Rorsman C, Ronnstrand L, Heldin CH, Waltenberger J, Bohmer FD, Levitzki A (1994) Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res 54:6106–6114 Kovalenko M, Gazit A, Bohmer A, Rorsman C, Ronnstrand L, Heldin CH, Waltenberger J, Bohmer FD, Levitzki A (1994) Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res 54:6106–6114
16.
go back to reference Laqua H, Machemer R (1975) Glial cell proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 80:602–618PubMed Laqua H, Machemer R (1975) Glial cell proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 80:602–618PubMed
17.
go back to reference Levitzki A, Gazit A (1995) Tyrosine kinase inhibition: an approach to drug development. Science 267:1782–1788PubMed Levitzki A, Gazit A (1995) Tyrosine kinase inhibition: an approach to drug development. Science 267:1782–1788PubMed
18.
go back to reference Limb GA, Little BC, Meager A, Ogilvie JA, Wolstencroft RA, Franks WA, Chignell AH, Dumonde DC (1991) Cytokines in proliferative vitreoretinopathy. Eye 5:686–693PubMed Limb GA, Little BC, Meager A, Ogilvie JA, Wolstencroft RA, Franks WA, Chignell AH, Dumonde DC (1991) Cytokines in proliferative vitreoretinopathy. Eye 5:686–693PubMed
19.
go back to reference Machemer R, Laqua H (1975) Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 80:1–23PubMed Machemer R, Laqua H (1975) Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 80:1–23PubMed
20.
go back to reference Milenkovic I, Weick M, Wiedemann P, Reichenbach A, Bringmann A (2003) P2Y receptor-mediated stimulation of Müller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation. Invest Ophthalmol Vis Sci 44:1211–1220CrossRefPubMed Milenkovic I, Weick M, Wiedemann P, Reichenbach A, Bringmann A (2003) P2Y receptor-mediated stimulation of Müller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation. Invest Ophthalmol Vis Sci 44:1211–1220CrossRefPubMed
21.
go back to reference Moll V, Weick M, Milenkovic I, Kodal H, Reichenbach A, Bringmann A (2002) P2Y receptor-mediated stimulation of Müller glial DNA synthesis. Invest Ophthalmol Vis Sci 43:766–773PubMed Moll V, Weick M, Milenkovic I, Kodal H, Reichenbach A, Bringmann A (2002) P2Y receptor-mediated stimulation of Müller glial DNA synthesis. Invest Ophthalmol Vis Sci 43:766–773PubMed
22.
go back to reference Newman EA (2001) Propagation of intercellular calcium waves in retinal astrocytes and Müller cells. J Neurosci 21:2215–2223PubMed Newman EA (2001) Propagation of intercellular calcium waves in retinal astrocytes and Müller cells. J Neurosci 21:2215–2223PubMed
23.
go back to reference Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402:884–888PubMed Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402:884–888PubMed
24.
go back to reference Rudolf K, Eberlein W, Engel W, Wieland HA, Willim KD, Entzeroth M, Wienen W, Beck-Sickinger AG, Doods HN (1994) The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur J Pharmacol 271:R11–R13PubMed Rudolf K, Eberlein W, Engel W, Wieland HA, Willim KD, Entzeroth M, Wienen W, Beck-Sickinger AG, Doods HN (1994) The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur J Pharmacol 271:R11–R13PubMed
25.
go back to reference Soler MV, Gallo JE, Dodds RA, Hokfelt T, Villar MJ, Suburo AM (2002) Y1 receptor of neuropeptide Y as a glial marker in proliferative vitreoretinopathy and diseased human retina. Glia 39:320–324CrossRefPubMed Soler MV, Gallo JE, Dodds RA, Hokfelt T, Villar MJ, Suburo AM (2002) Y1 receptor of neuropeptide Y as a glial marker in proliferative vitreoretinopathy and diseased human retina. Glia 39:320–324CrossRefPubMed
26.
go back to reference Soltoff SP (1998) Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2+]i elevation can substitute for receptor activation. J Biol Chem 273:23110–23117CrossRefPubMed Soltoff SP (1998) Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2+]i elevation can substitute for receptor activation. J Biol Chem 273:23110–23117CrossRefPubMed
27.
28.
go back to reference Straznicky C, Hiscock J (1989) Neuropeptide Y-like immunoreactivity in neurons of the human retina. Vision Res 29:1041–1048CrossRefPubMed Straznicky C, Hiscock J (1989) Neuropeptide Y-like immunoreactivity in neurons of the human retina. Vision Res 29:1041–1048CrossRefPubMed
29.
go back to reference Tsai W, Morielli AD, Peralta EG (1997) The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J 16:4597–4605CrossRefPubMed Tsai W, Morielli AD, Peralta EG (1997) The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J 16:4597–4605CrossRefPubMed
30.
go back to reference Uckermann O, Uhlmann S, Weick M, Pannicke T, Francke M, Reichenbach A, Wiedemann P, Bringmann A (2003) Upregulation of purinergic P2Y receptor-mediated calcium responses in glial cells during experimental detachment of the rabbit retina. Neurosci Lett 338:131–134CrossRefPubMed Uckermann O, Uhlmann S, Weick M, Pannicke T, Francke M, Reichenbach A, Wiedemann P, Bringmann A (2003) Upregulation of purinergic P2Y receptor-mediated calcium responses in glial cells during experimental detachment of the rabbit retina. Neurosci Lett 338:131–134CrossRefPubMed
31.
go back to reference Van Horn DL, Aaberg TM, Machemer R, Fenzl R (1977) Glial cell proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol 84:383–393PubMed Van Horn DL, Aaberg TM, Machemer R, Fenzl R (1977) Glial cell proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol 84:383–393PubMed
32.
go back to reference Weller M, Wiedemann P, Heimann K (1990) Proliferative vitreoretinopathy—is it anything more than wound healing at the wrong place? Int Ophthalmol 14:105–117PubMed Weller M, Wiedemann P, Heimann K (1990) Proliferative vitreoretinopathy—is it anything more than wound healing at the wrong place? Int Ophthalmol 14:105–117PubMed
33.
go back to reference Wiedemann P (1992) Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol 36:373–384CrossRefPubMed Wiedemann P (1992) Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol 36:373–384CrossRefPubMed
34.
go back to reference Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E, Grant DS (1998) Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83:187–195PubMed Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E, Grant DS (1998) Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83:187–195PubMed
Metadata
Title
Neuropeptide Y-evoked proliferation of retinal glial (Müller) cells
Authors
Ivan Milenkovic
Michael Weick
Peter Wiedemann
Andreas Reichenbach
Andreas Bringmann
Publication date
01-11-2004
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 11/2004
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-004-0954-3

Other articles of this Issue 11/2004

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2004 Go to the issue